文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome .

作者信息

Li Lei, Cui Herong, Li Tong, Qi Jinchai, Chen Hongshan, Gao Feng, Tian Xuehao, Mu Yunnong, He Rui, Lv Siyuan, Chu Fuhao, Xu Bing, Wang Penglong, Lei Haimin, Xu Hongri, Wang Chengxiang

机构信息

Respiratory Department, Beijing University of Chinese Medicine (BUCM) Third Affiliated Hospital, Beijing, China.

School of Chinese Pharmacy, BUCM, Beijing, China.

出版信息

Front Pharmacol. 2020 Aug 31;11:1210. doi: 10.3389/fphar.2020.01210. eCollection 2020.


DOI:10.3389/fphar.2020.01210
PMID:32982718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7490548/
Abstract

Diarrhea-predominant irritable bowel syndrome (IBS-D) is one common chronic functional disease of the digestive system with limited treatments. The microbiota-gut-brain axis (MGBA) has a central function in the pathogeny of IBS-D, which includes the participation of many various factors, such as brain-gut peptides (BGPs), immune inflammation, and intestinal flora. Inspired by the drug combination in traditional Chinese medicine (TCM), our previous study discovered that berberine (BBR) and baicalin (BA) could form natural self-assemblies as BA-BBR nanoparticles (BA-BBR NPs) and showed synergistic effects against IBS-D. Here, we investigated the synergistic effects of BA-BBR NPs on IBS-D model mice induced by chronic restraint stress plus Senna alexandrina Mill decoction with the influence on MGBA. BA-BBR NPs showed the best therapeutic effect on improving visceral hypersensitivity and diarrhea on IBS-D model mice, compared with BBR, BA, and BA/BBR mixture. Furthermore, BA-BBR NPs significantly (<0.05) reduced the levels of 5-hydroxytryptamine (5-HT), vasoactive intestinal polypeptide (VIP) and choline acety transferase (CHAT) in colon tissues or of serum from BGPs; it lowered the expressions of the nuclear factor kappa-B (NF-κB) in colon tissues and changed the levels of basophil granulocyte (BASO) and leukomonocyte (LYMPH) in whole blood from immune inflammation; it altered the intestinal flora of Bacteroidia, Deferribacteres, Verrucomicrobia, Candidatus_Saccharibacteria, and Cyanobacteria from intestinal flora. In conclusion, BA-BBR NPs, after forming the natural self-assembly between BBR and BA, promoted the synergistic effect on IBS-D mice than the sum of BBR and BA effects, based to the formation of self-assemblies rather than the simple mixing. It further proved that synergistic effect of BA-BBR NPs on IBS-D mice might be related to BGPs, immune inflammation, and intestinal flora from three important interrelated components of MGBA. This study will provide a novel idea for the interpretation of TCM compatibility theory and provide the basis for BA-BBR NPs as a medicinal plant-derived natural and efficient nanomaterial for clinical use.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/a53773554ae9/fphar-11-01210-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/fc20fc59a964/fphar-11-01210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/a63ccf0b61ba/fphar-11-01210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/199283b90321/fphar-11-01210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/6313a5d6b57d/fphar-11-01210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/0a485e834171/fphar-11-01210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/9ccad766cfef/fphar-11-01210-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/a53773554ae9/fphar-11-01210-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/fc20fc59a964/fphar-11-01210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/a63ccf0b61ba/fphar-11-01210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/199283b90321/fphar-11-01210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/6313a5d6b57d/fphar-11-01210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/0a485e834171/fphar-11-01210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/9ccad766cfef/fphar-11-01210-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f950/7490548/a53773554ae9/fphar-11-01210-g007.jpg

相似文献

[1]
Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome .

Front Pharmacol. 2020-8-31

[2]
Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.

World J Gastroenterol. 2019-8-7

[3]
The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.

mSystems. 2024-3-19

[4]
Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.

Front Pharmacol. 2022-5-9

[5]
Baizhu shaoyao decoction restores the intestinal barrier and brain-gut axis balance to alleviate diarrhea-predominant irritable bowel syndrome via FoxO1/FoxO3a.

Phytomedicine. 2024-1

[6]
The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.

Nutrients. 2024-4-18

[7]
Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome.

Front Microbiol. 2023-6-27

[8]
Dose-response effect of berberine on bile acid profile and gut microbiota in mice.

BMC Complement Altern Med. 2016-10-18

[9]
Altered gut microbiota-host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern.

Chin Med. 2023-7-19

[10]
Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora.

J Ethnopharmacol. 2019-3-19

引用本文的文献

[1]
Unveiling the renoprotective mechanisms of self-assembled herbal nanoparticles from and in acute kidney injury: A nano-TCM approach.

Acta Pharm Sin B. 2025-8

[2]
Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent.

Pharmaceuticals (Basel). 2025-1-31

[3]
Carrier-free nanoparticles-new strategy of improving druggability of natural products.

J Nanobiotechnology. 2025-2-14

[4]
Recent advances in self-targeting natural product-based nanomedicines.

J Nanobiotechnology. 2025-1-20

[5]
Traditional Chinese medicine for functional gastrointestinal disorders and inflammatory bowel disease: narrative review of the evidence and potential mechanisms involving the brain-gut axis.

Front Pharmacol. 2024-9-17

[6]
Recent Progress of Oral Functional Nanomaterials for Intestinal Microbiota Regulation.

Pharmaceutics. 2024-7-10

[7]
Natural Products from Herbal Medicine Self-Assemble into Advanced Bioactive Materials.

Adv Sci (Weinh). 2024-9

[8]
Nano-based drug delivery systems for active ingredients from traditional Chinese medicine: Harnessing the power of nanotechnology.

Front Pharmacol. 2024-6-7

[9]
The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.

Nutrients. 2024-4-18

[10]
Understanding multicomponent low molecular weight gels from gelators to networks.

J Adv Res. 2025-3

本文引用的文献

[1]
The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat.

Front Pharmacol. 2019-12-13

[2]
Self-Assemblies Based on Traditional Medicine Berberine and Cinnamic Acid for Adhesion-Induced Inhibition Multidrug-Resistant .

ACS Appl Mater Interfaces. 2019-12-20

[3]
Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.

Biomed Pharmacother. 2019-7-12

[4]
Natural Berberine-Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application.

ACS Nano. 2019-5-28

[5]
Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially.

Biomed Res Int. 2019-4-3

[6]
Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora.

J Ethnopharmacol. 2019-3-19

[7]
Baicalin exerts neuroprotective effects via inhibiting activation of GSK3β/NF-κB/NLRP3 signal pathway in a rat model of depression.

Int Immunopharmacol. 2018-9-6

[8]
Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders.

Front Pharmacol. 2018-8-21

[9]
Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.

Biomed Pharmacother. 2018-3

[10]
Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.

PLoS One. 2017-11-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索